As of April 2024 BeiGene has a market cap of $14.77 Billion. This makes BeiGene the world's 1181th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $14.77 B | -25.47% |
2023 | $19.81 B | -15.53% |
2022 | $23.46 B | -14.65% |
2021 | $27.48 B | 14.39% |
2020 | $24.03 B | 133.57% |
2019 | $10.28 B | 23.44% |
2018 | $8.33 B | 87.28% |
2017 | $4.45 B | 269.44% |
2016 | $1.20 B |
On Apr 17th, 2024 the market cap of BeiGene was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.85 B | -94.20% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | -99.86% | ๐บ๐ธ USA |